Welcome to the European Association for Cancer Research
Connecting cancer researchers together
Signalling Circuits in Cancer
Virtual Event : 10 - 11 February 2026
Scientific programme
To download and print the programme, use the links below.
Listed times are in Central European Time (CET)
WELCOME TO DAY ONE
Session 1
Session Chair: Chiara Ambrogio
The EMBO Keynote Lecture
Andreas Trumpp HI-STEM, Germany
'From stem cells in leukemia to neurons in pancreatic cancer'
Q&A 12:25-12:35
Janne Lehtiö Karolinska Institut, Sweden
'Proteogenomics for systems level analysis of genotype - molecular phenotype connections in cancer'
Q&A 12:55-13:05
Coralie Dessauges Harvard Medical School, USA
Proffered Paper 1: 'Prolonged BRAF targeted therapy leads to co-existing lineage states with distinct collective behaviors'
Q&A 13:15-13:20
Livia Perfetto Sapienza University of Rome, Italy
Proffered Paper 2: 'PatientProfiler, a novel tool to derive signalling-based biomarkers'
Q&A 13:30-13:35
REFRESHMENT BREAK
Session 2
Session Chair: Jukka Westermarck
Flash Talks Session 1
4 top-scoring abstracts presented as 3-minute flash talks
Zuzana Storchová RPTU, Germany
'Mechanisms Mitigating Cellular Stresses Triggered by Aneuploidy'
Q&A 14:25-14:35
Phuong-Hien Nguyen University of Cologne, Germany
Proffered Paper 3: 'Macrophage LYN signaling drives tumor progression and metabolic vulnerability in non-small cell lung cancer'
Q&A 14:45-14:50
REFRESHMENT BREAK
Flash Talks Session 2
4 top-scoring abstracts presented as 3-minute flash talks
Sabrina Digiovanni University of Turin, Italy
Proffered Paper 4: 'IRAK1 controls chemo-immuno-resistance in NSCLC'
Q&A 15:30-15:35
Debanjan Singha Roy Tel Aviv University, Israel
Proffered Paper 5: 'Drug Persistence to Resistance Evolution Analysis in Human Leukemia Reveals Diverse Leukemia-Initiating Cell Phenotypes'
Q&A 15:45-15:50
Arjun Raj Perelman School of Medicine, USA
'Building cellular memories as a mechanism of therapy resistance in melanoma'
Q&A 16:10-16:20
SUMMARY AND CLOSE
Listed times are in Central European Time (CET)
WELCOME TO DAY TWO
Session 3
Session Chair: Yaara Oren
Stephan Vagner Institut Curie, France
'The RNA binding activity of the BRAF kinase'
Q&A 12:25-12:35
Adrian Saurin University of Dundee, UK
'Understanding resistance to cell cycle-based chemotherapies'
Q&A 12:55-13:05
Jose L Orgaz Bueno Faculty of Health Sciences / University Carlos III of Madrid, Spain
Proffered Paper 6: 'Dedifferentiating melanomas rewire to actomyosin signaling during early adaptation to MAPK pathway inhibition'
Q&A 13:15-13:20
Gaia Giannitti Università degli Studi di Milano, Italy
Proffered Paper 7: 'Extracellular vesicles from adipocytes facilitate melanoma progression by enhancing mitochondrial bioenergetics'
Q&A 13:30-13:35
REFRESHMENT BREAK
Session 4
Session Chair: Venkatram Yellapragada
Flash Talks Session 3
4 top-scoring abstracts presented as 3-minute flash talks
Mihkel Örd Cancer Research UK Cambridge Institute, UK
Proffered Paper 8: 'Identifying cancer dependencies in peptide-interacting protein pocket'
Q&A 14:15-14:20
Lior Lobel Bar-Ilan University, Israel
'Gut Microbial Activity Modulates Cancer Immunotherapy'
Q&A 14:40-14:50
REFRESHMENT BREAK
Flash Talks Session 4
4 top-scoring abstracts presented as 3-minute flash talks
Melissa Junttila ORIC Pharmaceuticals Inc, USA
'PRC2 inhibition enhances sensitivity to androgen receptor pathway inhibitors by restricting adaptation of prostate tumors and inducing a luminal cell state'
Q&A 15:40-15:50
Guillermo de Cárcer Instituto de Investigaciones Biomédicas Sols-Morreale, Spain
Proffered Paper 9: 'Osmotic stress as a modulator of the response to microtubule-based therapies'
Q&A 16:00-16:05
DISCUSSION SESSION
Open Forum with SPC members Jukka Westermarck, Yaara Oren and Chiara Ambrogio
SUMMARY AND CLOSE
Key dates
Abstract submission deadline:
15 December 2025
Registration and Payment deadline:
19 January 2026
